Vanguard Group Inc Biote Corp. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Biote Corp. stock. As of the latest transaction made, Vanguard Group Inc holds 1,430,110 shares of BTMD stock, worth $6.42 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,430,110
Previous 1,417,793
0.87%
Holding current value
$6.42 Million
Previous $7.91 Million
13.16%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BTMD
# of Institutions
91Shares Held
18.6MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$20.4 Million12.7% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$10.9 Million5.9% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$7.21 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.35MShares$6.07 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX682KShares$3.06 Million0.0% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $34M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...